Siemens Healthineers : Q3 due 3 August – Inflation, supply chains, China weighing on the quarter
>Forecasting only a -1% y-o-y comparable revenue development - We forecast a -1% comparable revenue development for the group in Q3 (+4.8% y-o-y reported due to FX tailwind). We in particular expect rapid antigen test sales to decline y-o-y, but also see only flat Diagnostics revenues y-o-y underlying mainly on China lockdowns. Varian should have seen a revenue take up q-o-q on better shipments (up +20% y-o-y on a comparable basis). Imaging revenue growth will have be...Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.